• Pot entrepreneur: High growth expected for biz Friday, 22 Nov 2013 | 12:53 PM ET

    A Colorado medical marijuana dispensary became the first business in the U.S. licensed to sell recreational marijuana.

  • GlaxoSmithKline heart drug misses goal in major study Tuesday, 12 Nov 2013 | 6:17 AM ET

    An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.

  • Shire to pay $4.2 billion for ViroPharma Monday, 11 Nov 2013 | 4:21 AM ET

    London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.

  • FDA weighs generic drugmakers' accountability Friday, 8 Nov 2013 | 5:18 PM ET

    The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.

  • A marijuana muni bond?  Wednesday, 6 Nov 2013 | 1:47 PM ET

    CNBC's Tyler Mathisen, Jon Fortt and Michelle Caruso-Cabrera debate the money to be made from the legalization of marijuana.

  • Move over, Viagra. There's a new sex drug in town Thursday, 3 Oct 2013 | 1:52 PM ET

    You've heard of ED. Now there's a drug for PE, made by a 4-year-old start-up. It's designed for men to make their mates happier.

  • Will.i.am: prison problem is 'embarrassing'  Monday, 16 Sep 2013 | 7:00 PM ET

    Will.i.am talks to CNBC about the "failure" of the Drug Abuse Resistance Education program and how thousands of Americans are now in prison because of lack of opportunities in their neighborhood.

  • Studies back fast OK for Roche cancer drug: FDA Tuesday, 10 Sep 2013 | 1:58 PM ET

    The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.

  • Biogen makes another big bet on Isis technology Monday, 9 Sep 2013 | 10:53 AM ET

    Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop neurological medicines.

  • Legal pot creates jobs, big biz interested: Expert Friday, 30 Aug 2013 | 12:12 PM ET

    The cannabis legalization trend is creating jobs in states where laws have been relaxed, and big business is "looking into the industry in a big way," an expert says.

  • Pot stock scams  Tuesday, 20 Aug 2013 | 3:40 PM ET

    A warning about stock scams involving marijuana related companies has been issued; CNBC's Mary Thompson has the story.

  • Scammers target pot stocks  Tuesday, 20 Aug 2013 | 1:58 PM ET

    FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.

  • Marijuana stock shills are blowing smoke, US warns Tuesday, 20 Aug 2013 | 1:38 PM ET

    FINRA warned Tuesday that scammers have been targeting investors attempting to tap into the growing U.S. marijuana industry.

  • Rocky Mountain high... tracking pot from seed to sale  Thursday, 15 Aug 2013 | 7:45 AM ET

    Colorado and Washington are trying to figure out a system to regulate and track the use of legalized marijuana, reports CNBC's Jane Wells.

  • How legalizing cannabis could boost the economy  Tuesday, 13 Aug 2013 | 11:40 AM ET

    Doug Fine, author of 'Too High to Fail', explains the benefits to the economy that legalizing cannabis in the U.S. would have.

  • The evolution of the drugs trade  Monday, 12 Aug 2013 | 11:50 AM ET

    CNBC's Tom Mackenzie comments on the need for a globally coordinated approach to tackling the drugs trade.

  • The relationship between global drugs and banks  Monday, 12 Aug 2013 | 2:30 AM ET

    Steve Sampson, author of Narcomania: How Britain got hooked on drugs, tells CNBC that self-contradiction defines British drug policy.

  • Drug trade has become much more global: Expert  Monday, 12 Aug 2013 | 1:50 AM ET

    Vanda Felbab-Brown, senior fellow at the Brookings Institute, tells CNBC that the drug trade is becoming more global with demand coming out of the emerging markets.

  • Deadly epidemic: Prescription drug overdoses Wednesday, 24 Jul 2013 | 9:30 AM ET

    A growing epidemic of overdoses of prescription painkillers is leading to record numbers of deaths, especially among women, the Centers for Disease Control and Prevention says.

  • NFL players' big plays in digital  Tuesday, 23 Jul 2013 | 3:23 PM ET

    Life after the NFL is tough for players when they retire. A look at a few and their involvement in the tech industry, with Atlanta Falcons tight end Tony Gonzalez, of FitStar, and former NFL player Tony Mandarich, of the Mandarich Media Group.